441 related articles for article (PubMed ID: 23448373)
1. Mid-term outcomes of the Helex septal occluder for percutaneous closure of secundum atrial septal defects.
Correa R; Zahn E; Khan D
Congenit Heart Dis; 2013; 8(5):428-33. PubMed ID: 23448373
[TBL] [Abstract][Full Text] [Related]
2. Midterm follow-up of percutaneous closure of secundum atrial septal defect with Helex Septal Occluder.
Smith BG; Wilson N; Richens T; Knight WB
J Interv Cardiol; 2008 Aug; 21(4):363-8. PubMed ID: 18557802
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
4. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.
Jones TK; Latson LA; Zahn E; Fleishman CE; Jacobson J; Vincent R; Kanter K;
J Am Coll Cardiol; 2007 Jun; 49(22):2215-21. PubMed ID: 17543643
[TBL] [Abstract][Full Text] [Related]
5. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
[TBL] [Abstract][Full Text] [Related]
6. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
[TBL] [Abstract][Full Text] [Related]
7. Immediate and short-term outcomes after percutaneous atrial septal defect closure using the new nit-occlud ASD-R device.
Peirone A; Contreras A; Ferrero A; da Costa RN; Pedra SF; Pedra CA
Catheter Cardiovasc Interv; 2014 Sep; 84(3):464-70. PubMed ID: 24677704
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter closure of secundum atrial septal defect in children].
Gao W; Zhou AQ; Yu ZQ; Li F; Zhang YQ; Sun K; Zhong YM
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):287-90. PubMed ID: 15157392
[TBL] [Abstract][Full Text] [Related]
9. Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.
Javois AJ; Rome JJ; Jones TK; Zahn EM; Fleishman CE; Pignatelli RH; Latson LA;
JACC Cardiovasc Interv; 2014 Aug; 7(8):905-12. PubMed ID: 25147036
[TBL] [Abstract][Full Text] [Related]
10. A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.
Hill KD; Lodge AJ; Forsha D; Fleming GA; Green AS; Rhodes JF
Catheter Cardiovasc Interv; 2013 Mar; 81(4):654-9. PubMed ID: 22639441
[TBL] [Abstract][Full Text] [Related]
11. Developing High Medical Technology, a Challenge for Developing Countries: The Percutaneous Closure of Atrial Septal Defects Using Nit-Occlud ASD-R: Early and Mid-term Results.
Heath A; Alvensleben IV; Navarro J; Echazú G; Kozlik-Feldmann R; Freudenthal F
World J Pediatr Congenit Heart Surg; 2019 Jul; 10(4):433-439. PubMed ID: 31307309
[TBL] [Abstract][Full Text] [Related]
12. Follow-up results of transcatheter occlusion of atrial septal defects with buttoned device.
Rao PS; Ende DJ; Wilson AD; Smith PA; Chopra PS
Can J Cardiol; 1995 Sep; 11(8):695-701. PubMed ID: 7671179
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous ASD closure in a large Australian series: short- and long-term outcomes.
Walters DL; Boga T; Burstow D; Scalia G; Hourigan LA; Aroney CN
Heart Lung Circ; 2012 Sep; 21(9):572-5. PubMed ID: 22677131
[TBL] [Abstract][Full Text] [Related]
14. Helex septal occluder: feasibility study of closure of atrial septal defect.
El-Sisi AM; Gendi S; Dilawar M; Numan M
Pediatr Cardiol; 2008 Jan; 29(1):84-9. PubMed ID: 17899244
[TBL] [Abstract][Full Text] [Related]
15. Initial clinical experience with the GORE
de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
[TBL] [Abstract][Full Text] [Related]
16. Safety, feasibility, and long-term results of percutaneous closure of atrial septal defects using the Amplatzer septal occluder without periprocedural echocardiography.
Praz F; Wahl A; Schmutz M; Pfammatter JP; Pavlovic M; Perruchoud S; Remondino A; Windecker S; Meier B
J Invasive Cardiol; 2015 Mar; 27(3):157-62. PubMed ID: 25740969
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous closure of interatrial septal defects: mid-term follow-up results].
Oto MA; Aytemir K; Ozkutlu S; Kaya EB; Kabakcı G; Ateş AH; Yorgun H; Canpolat U
Turk Kardiyol Dern Ars; 2011 Jul; 39(5):385-95. PubMed ID: 21743262
[TBL] [Abstract][Full Text] [Related]
18. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
[TBL] [Abstract][Full Text] [Related]
20. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter U.S. IDE trial.
Gillespie MJ; Javois AJ; Moore P; Forbes T; Paolillo JA;
Catheter Cardiovasc Interv; 2020 Jun; 95(7):1296-1304. PubMed ID: 32108423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
